FDA / 2024

FDA approves first medication for obstructive sleep apnea

FDA approves first medication for obstructive sleep apnea — U.S. FDA (2024), cited in PeptideAgent's Tirzepatide evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2024
Source ID
fda-zepbound-osa

WHERE THIS IS CITED

Connected evidence records.

TirzepatidePeptide analog · Weight & Metabolism